Anthropometric Measurements and Diabetes Mellitus: Clues to the "Pathogenic" and "Protective" Potential of Adipose Tissue

被引:24
作者
Bays, Harold E. [1 ]
Fox, Kathleen M. [2 ]
Grandy, Susan [3 ]
机构
[1] Louisville Metab & Atherosclerosis Res Ctr, Louisville, KY USA
[2] Strateg Healthcare Solut LLC, Monkton, MD USA
[3] AstraZeneca Pharmaceut LP, Wilmington, DE USA
关键词
BODY-MASS INDEX; IMPROVE EARLY EVALUATION; ADIPOSOPATHY SICK FAT; METABOLIC SYNDROME; WAIST CIRCUMFERENCE; BLOOD-PRESSURE; INCREASED RISK; OBESITY; LEPTIN; PREVALENCE;
D O I
10.1089/met.2009.0089
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
100103 [病原生物学]; 100218 [急诊医学];
摘要
Background: Increased visceral adipose tissue (VAT) is "pathogenic" through adverse endocrine and immune contributions to metabolic diseases such as diabetes mellitus, hypertension, and dyslipidemia. Increased VAT increases waist circumference (WC), and WC is a recommended anthropometric measure of pathogenic adipose tissue distribution. Increased subcutaneous adipose tissue (SAT) is often described as "protective" against metabolic disease and frequently approximated by hip circumference (HC). Methods: The Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes (SHIELD) evaluated a study sample weighted to reflect the U. S. adult population. Respondents diagnosed with type 2 diabetes mellitus (T2DM; n = 3825) and without T2DM (n = 13,327) self-reported their weight and height, WC, and HC. Results: T2DM men and women had a disproportionate increase in body mass index (BMI) and WC, with 30% of T2DM men and 40% of T2DM women having a WC within the highest quintile compared to the overall study population. Waist-to-hip ratio (WHR) appeared to be the best anthropometric predictor of T2DM. However, both T2DM men and women also had a disproportionate increase in HC, with 30% of T2DM men and 34% of T2DM women having a HC within the highest quintile, which was generally similar to the distribution of BMI and WHR. Conclusions: This analysis suggests that: (1) An increase in adipose tissue generally increases the risk of T2DM; (2) central adiposity is more pathogenic than peripheral subcutaneous adiposity; and (3) SAT accumulation, as assessed by increased HC, does not always "protect" against metabolic diseases such as T2DM.
引用
收藏
页码:307 / 315
页数:9
相关论文
共 70 条
[1]
Relationship of generalized and regional adiposity to insulin sensitivity in men with NIDDM [J].
Abate, N ;
Garg, A ;
Peshock, RM ;
StrayGundersen, J ;
AdamsHuet, B ;
Grundy, SM .
DIABETES, 1996, 45 (12) :1684-1693
[2]
The obesity paradox: Impact of obesity on the prevalence and prognosis of cardiovascular diseases [J].
Artham, Surya M. ;
Lavie, Carl J. ;
Milani, Richard V. ;
Ventura, Hector O. .
POSTGRADUATE MEDICINE, 2008, 120 (02) :34-41
[3]
Avila-Funes J A, 2004, J Nutr Health Aging, V8, P355
[4]
Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease [J].
Baker, Adam R. ;
da Silva, Nancy F. ;
Quinn, David W. ;
Harte, Alison L. ;
Pagano, Domenico ;
Bonser, Robert S. ;
Kumar, Sudhesh ;
McTernan, Philip G. .
CARDIOVASCULAR DIABETOLOGY, 2006, 5 (1)
[5]
Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: Peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach [J].
Bays, H ;
Mandarino, L ;
DeFronzo, RA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (02) :463-478
[6]
Is adiposopathy (sick fat) an endocrine disease? [J].
Bays, H. E. ;
Gonzalez-Campoy, J. M. ;
Henry, R. R. ;
Bergman, D. A. ;
Kitabchi, A. E. ;
Schorr, A. B. ;
Rodbard, H. W. ;
Grp, Adiposopathy Working .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2008, 62 (10) :1474-1483
[7]
The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys [J].
Bays, H. E. ;
Chapman, R. H. ;
Grandy, S. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2007, 61 (05) :737-747
[8]
Adiposopathy: why do adiposity and obesity cause metabolic disease? [J].
Bays, Harold ;
Ballantyne, Christie .
FUTURE LIPIDOLOGY, 2006, 1 (04) :389-420
[9]
Adiposopathy is a more rational treatment target for metabolic disease than obesity alone [J].
Bays H. ;
Dujovne C.A. .
Current Atherosclerosis Reports, 2006, 8 (2) :144-156
[10]
Adiposopathy, metabolic syndrome, quantum physics, general relativity, chaos and the Theory of Everything [J].
Bays, Harold .
EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2005, 3 (03) :393-404